Cargando…

SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19

BACKGROUND: COVID‐19 may present with a variety of cardiovascular manifestations, and elevations of biomarkers reflecting myocardial injury and stress are prevalent. SARS‐CoV‐2 has been found in cardiac tissue, and myocardial dysfunction post‐COVID‐19 may occur. However, the association between SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Myhre, Peder L., Prebensen, Christian, Jonassen, Christine Monceyron, Berdal, Jan Erik, Omland, Torbjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200723/
https://www.ncbi.nlm.nih.gov/pubmed/33596668
http://dx.doi.org/10.1161/JAHA.120.019756
_version_ 1783707667525533696
author Myhre, Peder L.
Prebensen, Christian
Jonassen, Christine Monceyron
Berdal, Jan Erik
Omland, Torbjørn
author_facet Myhre, Peder L.
Prebensen, Christian
Jonassen, Christine Monceyron
Berdal, Jan Erik
Omland, Torbjørn
author_sort Myhre, Peder L.
collection PubMed
description BACKGROUND: COVID‐19 may present with a variety of cardiovascular manifestations, and elevations of biomarkers reflecting myocardial injury and stress are prevalent. SARS‐CoV‐2 has been found in cardiac tissue, and myocardial dysfunction post‐COVID‐19 may occur. However, the association between SARS‐CoV‐2 RNA in plasma and cardiovascular biomarkers remains unknown. METHODS AND RESULTS: COVID MECH (COVID‐19 Mechanisms) was a prospective, observational study enrolling consecutive, hospitalized patients with laboratory‐confirmed infection with SARS‐CoV‐2 and symptoms of COVID‐19. Biobank plasma samples used to measure SARS‐CoV‐2 RNA and cardiovascular and inflammatory biomarkers were collected in 123 patients at baseline, and in 96 patients (78%) at day 3. Patients were aged 60±15 (mean ± SD) years, 71 (58%) were men, 68 (55%) were White, and 31 (25%) received mechanical ventilation during hospitalization. SARS‐CoV‐2 RNA was detected in plasma from 48 (39%) patients at baseline. Patients with viremia were more frequently men, had more diabetes mellitus, and lower oxygen saturation. Patients with viremia had higher concentrations of interleukin‐6, C‐reactive protein, procalcitonin, and ferritin (all <0.001), but comparable levels of cTnT (cardiac troponin T; P=0.09), NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide; P=0.27) and D‐dimer (P=0.67) to patients without viremia. SARS‐CoV‐2 RNA was present in plasma at either baseline or day 3 in 50 (52%) patients, and these patients experienced increase from baseline to day 3 in NT‐proBNP and D‐dimer concentrations, while there was no change in cTnT. CONCLUSIONS: SARS‐CoV‐2 viremia was associated with increased concentrations of inflammatory, but not cardiovascular biomarkers. NT‐proBNP and D‐dimer, but not cTnT, increased from baseline to day 3 in patients with viremia. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04314232.
format Online
Article
Text
id pubmed-8200723
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82007232021-06-15 SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19 Myhre, Peder L. Prebensen, Christian Jonassen, Christine Monceyron Berdal, Jan Erik Omland, Torbjørn J Am Heart Assoc Brief Communication BACKGROUND: COVID‐19 may present with a variety of cardiovascular manifestations, and elevations of biomarkers reflecting myocardial injury and stress are prevalent. SARS‐CoV‐2 has been found in cardiac tissue, and myocardial dysfunction post‐COVID‐19 may occur. However, the association between SARS‐CoV‐2 RNA in plasma and cardiovascular biomarkers remains unknown. METHODS AND RESULTS: COVID MECH (COVID‐19 Mechanisms) was a prospective, observational study enrolling consecutive, hospitalized patients with laboratory‐confirmed infection with SARS‐CoV‐2 and symptoms of COVID‐19. Biobank plasma samples used to measure SARS‐CoV‐2 RNA and cardiovascular and inflammatory biomarkers were collected in 123 patients at baseline, and in 96 patients (78%) at day 3. Patients were aged 60±15 (mean ± SD) years, 71 (58%) were men, 68 (55%) were White, and 31 (25%) received mechanical ventilation during hospitalization. SARS‐CoV‐2 RNA was detected in plasma from 48 (39%) patients at baseline. Patients with viremia were more frequently men, had more diabetes mellitus, and lower oxygen saturation. Patients with viremia had higher concentrations of interleukin‐6, C‐reactive protein, procalcitonin, and ferritin (all <0.001), but comparable levels of cTnT (cardiac troponin T; P=0.09), NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide; P=0.27) and D‐dimer (P=0.67) to patients without viremia. SARS‐CoV‐2 RNA was present in plasma at either baseline or day 3 in 50 (52%) patients, and these patients experienced increase from baseline to day 3 in NT‐proBNP and D‐dimer concentrations, while there was no change in cTnT. CONCLUSIONS: SARS‐CoV‐2 viremia was associated with increased concentrations of inflammatory, but not cardiovascular biomarkers. NT‐proBNP and D‐dimer, but not cTnT, increased from baseline to day 3 in patients with viremia. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04314232. John Wiley and Sons Inc. 2021-04-23 /pmc/articles/PMC8200723/ /pubmed/33596668 http://dx.doi.org/10.1161/JAHA.120.019756 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communication
Myhre, Peder L.
Prebensen, Christian
Jonassen, Christine Monceyron
Berdal, Jan Erik
Omland, Torbjørn
SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
title SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
title_full SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
title_fullStr SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
title_full_unstemmed SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
title_short SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
title_sort sars‐cov‐2 viremia is associated with inflammatory, but not cardiovascular biomarkers, in patients hospitalized for covid‐19
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200723/
https://www.ncbi.nlm.nih.gov/pubmed/33596668
http://dx.doi.org/10.1161/JAHA.120.019756
work_keys_str_mv AT myhrepederl sarscov2viremiaisassociatedwithinflammatorybutnotcardiovascularbiomarkersinpatientshospitalizedforcovid19
AT prebensenchristian sarscov2viremiaisassociatedwithinflammatorybutnotcardiovascularbiomarkersinpatientshospitalizedforcovid19
AT jonassenchristinemonceyron sarscov2viremiaisassociatedwithinflammatorybutnotcardiovascularbiomarkersinpatientshospitalizedforcovid19
AT berdaljanerik sarscov2viremiaisassociatedwithinflammatorybutnotcardiovascularbiomarkersinpatientshospitalizedforcovid19
AT omlandtorbjørn sarscov2viremiaisassociatedwithinflammatorybutnotcardiovascularbiomarkersinpatientshospitalizedforcovid19